Knowledge

Insights and Analysis

31 January 2023

In this first issue of our quarterly Life Science Law Update, our teams highlight key trends across life sciences regulatory, corporate, compliance, competition, and privacy throughout the...

News

31 January 2023

The last year has seen a huge amount of change, both politically and economically, which has also been reflected in a constant array of new government policies. What is coming down the line ...

News

31 January 2023

In a debate in the House of Commons on Wednesday 26 January 2023, MP Tom Tugendhat indicated that a major reform to corporate criminal liability is imminent. In this article, we take a look ...

News

31 January 2023

The U.S. Food and Drug Administration (FDA) has several programs available that can expedite the development and regulatory review of a drug or biological product, including Accelerated...

News

31 January 2023

In an official statement last week, the U.S. Food and Drug Administration (FDA) announced its conclusion that the existing regulatory framework for foods and dietary supplements is not...

News

30 January 2023

In a debate in the House of Commons on Wednesday 26 January 2023, MP Tom Tugendhat indicated that a major reform to corporate criminal liability is imminent. In this article, we take a look ...

Insights and Analysis

30 January 2023

On 28 September 2022, Italian Legislative Decrees no. 137/2022 and 138/2022 entered into force. The two Legislative Decrees aim to adjust the Italian legal framework on medical devices to...

News

30 January 2023

This is the January edition of Anchovy News. Here you will find articles concerning ICANN, the domain name industry and the recuperation of domain names across the globe. In this issue we...

News

30 January 2023

Due to the anonymity of non-fungible tokens’ (“NFTs”) transactions, sellers face practical difficulties in determining whether or not they should charge Spanish Value...